Joseph Martial

Labage SA engages in the development of software solutions and web-based tools for the management of technical expertise, research and development data, and resources using collective intelligence technologies. Its main product Benchsys is a software constructed as an adaptive case management system from the ground up, with the flexibility in mind and the human being right in the centre of user organization. The company was founded by Andre Renard and Christian Renard in 2002 and is headquartered in Liege, Belgium.

Targetome SA operates is a biotech company which develops affinity-based targeted therapies against unmet medical needs with initial focus on pancreatic cancer and liver metastases. The firm develops antibody-drug conjugates. The company was founded by Edwin de Pauw and Vincent Castronovo in 2010 and is headquartered in Liege, Belgium.

Probiox SA engages in the development and commercialization of solutions based on oxidative stress markers. The firm owns intellectual property related to the analysis and interpretation of oxidative stress parameters. It also provides turnkey solutions to companies for the evaluation of the antioxidant/anti-inflammatory properties of their products. The company's services include intellectual deliveries (literature reviews and scientific records for starting projects, registrations, claims, marketing support and scientific survey), clinical studies (assessment of oxidative stress in the context of existing studies or conducting turnkey studies) and In Vitro studies. Probiox was founded in 2001 and is headquartered in Liege, Belgium.

ImCyse SA engages in the development of curative therapies in the field of immune and allergic pathologies. It offers a technological platform that helps develop medicinal products with potential benefits in all clinical circumstances where HLA class II restricted specific immunity can be causative of or contribute to damages to humans or animals. The firm's products are used in organ-specific autoimmunity, allergy, alloimmunity, cancer and infectious diseases. The company was founded in August 2010 by Jean-Marie R. Saint-Remy and is headquartered in Liege, Belgium.

Kaneka Eurogentec SA distributes reagents, kits and other related products for the biotechnology, pharmaceutical, and diagnostic sectors. It offers a range of services, from basic research in genomics and proteomics, to services associated with the development and manufacture of diagnostic and therapeutic products. The company was founded in 1985 and is headquartered in Seraing, Belgium.